Insider Trading History of Elston George

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Elston George since 2016. This trader's CIK number is 1429932. At the time of last reporting, Elston George was the Chief Financial Officer of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT). Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..

Note that in the past Elston George also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Juniper Pharmaceuticals Inc (JNP) by Elston George

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 JNP 1,000 $5,500 0 $0 0 $0

Yearly summary of insider trading at Eyepoint Pharmaceuticals, Inc. (EYPT) by Elston George

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 EYPT 0 $0 0 $0 43,619 $0
2024 EYPT 0 $0 0 $0 26,085 $0
2023 EYPT 0 $0 0 $0 10,800 $0
2020 EYPT 30,000 $20,510 0 $0 0 $0
2019 EYPT 10,000 $14,290 0 $0 0 $0


Insider trading activities at 2 companies by Elston George:

1. Juniper Pharmaceuticals Inc (JNP)

2. Eyepoint Pharmaceuticals, Inc. (EYPT)

Table 1. Insider trading of Juniper Pharmaceuticals Inc (JNP) by Elston George

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-08-31 JNP Buy 1,000 5.50 5,500

Table 2. Insider trading of Eyepoint Pharmaceuticals, Inc. (EYPT) by Elston George

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-25 EYPT Option Ex 7,500 .00 0
2025-02-09 EYPT Option Ex 5,834 .00 0
2025-01-05 EYPT Option Ex 15,000 .00 0
2025-01-06 EYPT Option Ex 15,285 .00 0
2024-02-09 EYPT Option Ex 10,800 .00 0
2024-01-06 EYPT Option Ex 15,285 .00 0
2023-02-09 EYPT Option Ex 10,800 .00 0
2020-09-04 EYPT Buy 10,000 .48 4,800
2020-08-24 EYPT Buy 10,000 .61 6,110
2020-03-12 EYPT Buy 10,000 .96 9,600
2019-11-15 EYPT Buy 10,000 1.43 14,290

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elston George (Chief Financial Officer of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.